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Abstract 
In our preliminary radiopharmaceutical study, 153Gd-DTPA-Folate has been successfully prepared, and tested for its bio-
distribution. This continuing study is aimed at synthesizing and characterizing Gd-DTPA-Folate. The synthesis was started with 
the preparation of a derivative of folic acid, EDA-Folate, which was subsequently reacted with DTPA-Dianhydride to form 
DTPA-Folate. Finally, DTPA-Folate was reacted with Gd3+ to result in Gd-DTPA-Folate, on a 0.1-10 gram scale, with a yield of 
97.2%. Experimental data collected from characterization of purified synthetic products using ultraviolet, infrared, and mass 
spectroscopy, indicated the formation of Gd-O and Gd-N bonds leading to the formation of Gd-DTPA-Folate molecule. 
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1. Introduction 
Nowadays cancer has been a major cause of death in the world, and the incidents of the disease tend to increase 
rapidly. About 12.7 million peoples have been diagnosed to have cancer every year, and 7.6 million of them were 
dead, mostly those having cervix and breast cancers. In Indonesia, cancer has been in the top ninth of the list of 50 
death causing diseases1.  
Magnetic Resonance Imaging (MRI) is able to detect cancer more rapidly than other diagnosis techniques can 
do.  Furthermore, there are some more superiorities of MRI as a diagnosis method over the others, among others are 
its much smaller hazardous effect of radiation than those of such other methods as Computer Topography (CT) and 
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Ultrasonography (US), and its non-invasive character2. MRI diagnosis technique has taken the advantage of using 
what so called contrast agents, which function to improve the quality of image produced. A contrast agent that has 
been recommended by the US FDA since 1988 is gadolinium-diethylene triamine pentaacetate (Gd-DTPA), with its 
brand name Magnevist3. This contrast agent cannot, however, be used to specifically detect cancers4. Thus, for this 
purpose a new type of contrast agents, targeted contrast agents, have been developed. This new type of contrast 
agents contains, in their molecular structures, a ligand having a high affinity to receptors on cancer cells. The ligand 
functions to direct the whole molecule of the contrast agent to go to the targets, the cancer cells, and thus do imaging 
specifically5. In the case of folic acid is the ligand, this has taken placed through the folate-mediated endocytosis 
mechanism6.  
So far, three radiopharmaceutical preparations have been synthesized by conjugating folic acid with radioactive-
labelled ligands; all of them have been evaluated for their use as tumor markers. They are 67Ga-deferoxamine-
folate5, 111In-DTPA-Folate5, and 99Tc-DTPA-Folate7. 
In our preliminary radiopharmaceutical study, 153Gd-DTPA-Folate has been successfully prepared and tested for 
its bio-distribustion8. This work is a continuing study aimed to synthesize and characterize Gd-DTPA-Folate, as a 
candidate for a targeted contrast agent. 
2. Materials and Methods 
2.1. Materials 
2.1.1. Apparatus 
 
This research employed instrumentation to include those for melting point determination (MP50 Melting point 
Mettler Toledo), a centrifuge, an ultraviolet spectrophotometer (UV HP 8452 A Shimadzu), an infrared spectrometer 
(FTIR Spectrum, Perkin Elmer), a liquid chromatograph-mass spectrometer (Waters LC-MS ESI-TOF), a high 
performance liquid chromatograph (Waters), a magnetic stirrer, a vacuum evaporator, a vacuum desicator, and other 
general laboratory glass apparatus.  
 
2.1.1. Chemicals 
 
Chemicals were purchased from Sigma Aldrich and Merck, and were of reagent- and or analytical grade. They 
included 2-propanol, γ-methyl glutamic acid, aquabidest, folic acid, hydrochloric acid, acetone, acetonitrile, 
diethyleter, diethylenetriaminepentaacetic dianhydride, dimethylsulfoxide, ethylenediamine, gadolinium chloride 
hexahydrate, hydrazine hydrate, potassium cyanide, methyl alcohol, sodium azide, sodium hydroxide, tertiary butyl 
nitrile, tetrahydrofurane, tetramethyl guanidine and trifluoroacetic anhydride.  
 
2.2. Methods 
2.2.1. Synthesis of EDA-Folate  
 
EDA-Folate was synthesized from folic acid through the method of five reaction steps. The five reactions steps 
were (consecutively): 1. Cyclization of the end part of the side chain of folic acid molecule; 2. Formation of a 
hydrazide from the reaction product of the first step reaction; 3. Formation of an azide from the hydrazide formed in 
the second step reaction; 4. Formation of a methyl ester of folic acid from the azide resulted in the third step 
reaction; and 5. Formation of EDA-Folate from the reaction of methyl ester formed in the fourth step reaction. 
 
2.2.1. Syntesis of DTPA-Folate (γ)  
 
EDA-Folate (γ) (0.1 g) was dissolved in dimethyl sulfoxide (5 mL). The resulted solution was then slowly added 
into a suspension of diethylenetriaminepentaacetic dianhydride (2 g) in dimethyl sulfoxide (1 mL). The result of the 
reaction mixture was cooled on an ice bath, neutralized with 2.4 N sodium hydroxide solution (1 mL), and then 
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centrifuged. The formed yellow precipitate was washed with acetonitrile and dissolved in water. The pH of the 
resulted solution was adjusted to 7.0 with a dilute hydrochloric acid solution. The produced light yellow solution 
was finally filtered, and evaporated to dryness, leaving a yellow solid product. The final reaction product was 
analyzed by TLC and HPLC. A concentrated aqueous solution of the product was passed onto a preparative 
reversed-phase chromatographic column using a stationary phase of octadecylsilane (ODS) and a mobile phase of 
methanol:water (1:9). The collected fractions were analyzed by HPLC, and those fractions containing DTPA-Folate 
were evaporated to get a pure DTPA-Folate product.   
2.2.2. Synthesis of Gd-DTPA-Folate9 
 
To 0.204 g (5.5 x 10-2 mmole) of GdCl3.6 H2O and 0.429 g (5 x 10
-2 mmole) of the synthesized DTPA-Folate in a 
round-bottom flask, 10 mL of aquabidest was added.  The reaction mixture was then heated under reflux condensor 
for 2 hours. The resulted reaction mixture was neutralized, filtered, and dried in a freeze dryer. The produced yellow 
solid was analyzed by HPLC and TLC. A concentrated aqueous solution of the product was passed to preparative 
chromatographic column with a stationary phase of ODS and a mobile phase of methanol:water (1:9).  
Chromatographic fractions were collected and analyzed by HPLC and TLC. All the fractions containing Gd-DTPA-
Folate were combined, evaporated, and the purified product was characterized using ultraviolet-, infrared-, and mass 
spectrometry. The melting point of the reaction product was also determined. 
3. Results and Discussion 
3.1. Syntesis of EDA-Folate 
The MRI contrast agent Gd-DTPA-Folate being studied will be a new product developed from the earlier contrast 
agent Gd-DTPA, which has long been used in medical diagnosis. The new contrast agent is different from Gd-
DTPA, in that the former will be able to detect cancer, while the latter cannot; Gd-DTPA is a general and non-
specific contrast agent. 
This has been made possible because the molecule of this particular new type of contrast agent has the folate 
group in it, which is able to direct the whole contrast agent molecule to go to the folate receptor (that is why this 
type of contrast agent is called targeted contrast agent) on the surface of cancer cells. In other words, the contrast 
agent detects the cancer cells. The interaction of folic acid with the folate receptor on the cancer cells occurs 
(expression on normal cells is less than that on cancer cells), through the folate-mediated endocytosis. 
Gd-DTPA-Folate was formed from the reaction of Gd3+ with DTPA-Folate, which was freshly synthesized via the 
reaction between DTPA-dianhydride and EDA-Folate, which was previously prepared by adopting and modifying 
the long route but established method9. In this method, folic acid was converted consecutively into pyrofolic acid, 
pteroyl hydrazide, pteroyl azide, methyl ester of folic acid, and finally into EDA-Folate (Figure 1).  
 
 
 
Fig. 1.  Reaction steps in the synthesis of EDA-Folate from folic acid (Adopted from US 20070042970 Patent)9 
 
Thus, the success in the preparation of EDA-Folate as an important precursor, depends on how each of the reaction 
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steps to form the intermediate was carried out. This includes optimization of the reaction conditions and purification 
process. Figure 2 below is a histogram showing the yield of each reaction step during the preparation of EDA-Folate 
from folic acid. 
    
 
     Fig. 2.  Yield of reaction steps during the preparation of EDA-Folate from folic acid (derivates of folic acid). (a) Pyrofolic acid, (b) Pteroyl  
hydrazide, (c) Pteroyl azide, (d) Methyl ester folic acid (γ), and (e) EDA-folate (γ). 
 
Figure 2 shows that the yield of four out of the five reaction steps were more than 70%, which are good.  But, 
optimization of the conditions of the third reaction step (Figure 1), such as formation reaction of pteroyl hydrazide 
from pteroyl azide with a yield of 50%, still have to be done. 
Apart from the yields of the reactions, purity of the reaction products is another important aspect. Thus, all the 
reaction products have been purified and analyzed for their purity by chromatographic methods. 
 
3.2. Syntesis of DTPA-Folate 
DTPA-Folate was synthesized through a substitution reaction of DTPA-dianhydride with EDA-Folate, which had 
been prepared freshly. The reaction involved an amidation of the primary amine in the EDA-Folate molecule with 
one of the carboxyl groups in the DTPA molecule. The molecular structure of the resulted DTPA-Folate is shown 
below in Figure 3. 
 
 
Fig. 3.  Molecular structure of DTPA-Folate. 
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Purification of the produced DTPA-Folate (also EDA-Folate and DTPA-dianhydride which was done on a reversed-
phase chromatographic column, C18, with a mobile phase of a methanol:water, mixture (1:9) has resulted in a 
sufficiently pure product required for its characterization. Figure 4 below is a chromatogram of the purified product 
of DTPA-Folate. 
 
 
 
     Fig. 4.  HPLC chromatogram of the resulted DTPA-Folate. Chromatographic conditions were: C18 column, isocratic elution with a mobile   
phase  of a mixture of acetonitrile: 0.3% TFA (2:8), flow rate of 1 mL/minute, ultraviolet detection at 280 nm. 
 
The chromatogram shows a single peak at 2.4 minutes, indicating that the resulted DTPA-Folate was pure and thus 
can be used further for the synthesis of Gd-DTPA-Folate (Fig. 6)..  
3.3. Synthesis Gd-DTPA-Folate 
Gd-DTPA-Folate was synthesized via a complexation reaction of Gd3+ ion with DTPA-Folate that had been 
synthesized previously. Figure 5 below is a proposed molecular structure of the resulted complex. 
 
 
 
Fig. 5.  A proposed molecular structure of the synthesized Gd-DTPA-Folate. 
 
As shown in Figure 5, seven chemical bonds were formed from gadolinium atom, nitrogen atoms and oxygen 
atoms, consisting of four Gd-O and three Gd-N bonds. These had been made possible to occur because of the 
presence of the lone pair electrons on the nitrogen and oxygen atoms. The electron pairs were shared with 
gadolinium atom in the formation of the complex molecule, formation of Gd-O and Gd-N bonds.   
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In order the reaction to take place more rapidly and completely, one of the reactants, Gd3+ ion was added in excess, 
more than the required amount calculated based on reaction stoichiometry. Applying the selected experimental 
conditions, it was found that the reaction took placed almost completely in two hours, to result in a yield of 97.2%.   
 
 
 
     Fig. 6.  HPLC chromatogram of the resulted Gd-DTPA-Folate. Chromatographic conditions were: C18 column, isocratic elution with a mobile  
phase of a mixture of acetonitrile: 0.3% TFA (2:8), flow rate of 1 mL/minute, ultraviolet detection at 280 nm. 
 
Apart from the yields of the reactions, purity of the reaction products is another important aspect. Thus, all the 
reaction products have been purified and analyzed for their purity by chromatographic methods. Data on melting 
point of the synthesized products confirm that the products were pure as indicated by their melting points data 
(DTPA-Folate, 73.0 – 73.4°C; Gd-DTPA-Folate, 100.5 – 101.0°C). 
Characterization of the synthesized contrast agent and the precursor was done by using different methods of 
spectroscopy; they were ultraviolet-, infrared-, and mass spectroscopy. The following is the ultraviolet spectra of the 
synthesized DTPA-Folate (Figure 7a). 
 
Fig. 7.  Ultraviolet spectra of synthesized DTPA-Folate (a) and ultraviolet spectra of Gd-DTPA-Folate (b) in the range of 200-400 nm. 
 
The ultraviolet spectra of the synthesized DTPA-Folate show an absorption peak at 280 nm originated from the 
C=C bonds of the benzene rings (electronic transisition from ߨoߨ*), and an absorption peak at 362 nm coming 
from the conjugated C=O bonds (electronic transisition from n o ߨ*) (see the molecular structure of DTPA-Folate 
(Figure 3).  
Meanwhile, the ultraviolet spectra of the synthesized Gd-DTPA-Folate (Figure 7b) show an absorption peak at 256 
nm, other than those on 280 nm and 362 nm. These latter two absorption peaks are present in the ultraviolet spectra 
of the synthesized DTPA-Folate10. From this comparison of the ultraviolet spectra of the two synthesized 
compounds it can be drawn a conclusion that the absorption peak at 256 nm originated from the formation of the 
complex compound or new bonds, the Gd-O and Gd-N bonds, because of hypsochromic effect (see the proposed 
molecular structural of Gd-DTPA-Folate in Figure 5). The higher intensity of the absorption peak of DTPA-Folate 
in the region of 272-278 nm was probably due to the presence of gadolinium atom in the molecule of Gd-DTPA-
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Folate as well.  Infrared spectra of the synthesized compounds are presented in Figure 8 below.  
 
 
Fig. 8. Infrared spectra of the synthesized DTPA-Folate (a) and Gd-DTPA-Folate (b) the wave number range of 450-4,000 cm-1. 
 
From a comparison between the infrared spectra of the synthesized DTPA-Folate (Fig. 8a) and that of the 
synthesized Gd-DTPA-Folate (Figure 8b) it can be seen the presence of absorptions at similar wave-numbers, both 
in the functional group region (4,000 – 1,400 cm-1) and in the finger print region (1,400 – 400 cm-1). The absorption 
peaks are: at 3,434.8 cm-1, originating from the stretching vibration of O-H and or N-H groups; at 2,890.1 cm-1 from 
the stretching vibration of C-H groups;  and at 934.2 cm-1 from C-O and C-N groups; and at 792.5 cm-1 from C-H 
groups. An identified difference is the presence of an absorption at 452.1 cm-1 in the spectra of Gd-DTPA-Folate, 
but not in the spectra of DTPA-Folate, which probably comes from vibration of Gd-O bonds. Another difference 
between the two synthesized spectra is the lower absorption intensity of OH groups in Gd-DTPA-Folate at the wave 
number of 3,434.3 cm-1 than that of in DTPA-Folate. This may be due to the binding of the OH groups in DTPA-
Folate molecule by Gd3+. 
Mass spectra of the synthesized compounds are presented in Figure 9 below.  
 
Fig.. 9.  Mass spectra of the synthesized DTPA-Folate (a) and Gd-DTPA-Folate (b), in the m/z range of 100-1,100. 
Mass spectra the prepared DTPA-Folate (Fig. 9a) show the presence of a parent peak at an m/z of 855.1005, which 
corresponds to a calculated molecular mass of the compound. Meanwhile, mass spectra of the produced Gd-DTPA-
Folate (Fig. 9b) show the presence of a parent peak at an m/z of 1034.41, which corresponds to the calculated 
molecular mass of the synthesized candidate for a targeted contrast agent, as its sodium salt. 
Conclusions 
Based on the discussions given above, the conclusion of this study is that Gd-DTPA-Folate could successfully be 
synthesized in a good yield, from the reaction of gadolinium ion with DTPA-Folate, which was freshly prepared 
from EDA-Folate, which in turn was synthesized from folic acid, through several reaction steps. The Gd-DTPA-
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Folate product was produced on a 0.1-10 gram scale, in the form of pale yellow crystals. 
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